<DOC>
	<DOCNO>NCT03082053</DOCNO>
	<brief_summary>The purpose study explore safety efficacy varlitinib administer monotherapy Japanese subject advance metastatic solid tumor , administer combination capecitabine Japanese subject advance metastatic biliary tract cancer . Also evaluate pharmacokinetics ( PK ) varlitinib , capecitabine metabolite .</brief_summary>
	<brief_title>A Study Varlitinib Japanese Subjects With Advanced Metastatic Solid Tumours</brief_title>
	<detailed_description />
	<mesh_term>Biliary Tract Neoplasms</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<criteria>Study I : Subjects solid tumour ( exclude haematologic tumor ) advance metastatic stage Study II : Subjects advance ( unresectable ) metastatic biliary tract cancer ( IHCC , EHCC , gallbladder cancer ampullary carcinoma ) Subjects concurrent multiple primary cancer . Subjects history ( noninfectious ) pneumonitis require steroid current pneumonitis , history interstitial lung disease current interstitial lung disease Subjects receive proton pump inhibitor establish , symptomatic gastroduodenal ulceration gastroesophageal reflux disease ( include preventive use )</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>